LUCD NASDAQ
Lucid Diagnostics Inc.
1W: -24.1%
1M: -36.6%
3M: -41.9%
YTD: -44.0%
1Y: -38.5%
3Y: -57.3%
$0.63
-0.01 (-1.18%)
Weekly Expected Move ±11.8%
$0
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
12 relationships6
As Filer
counterparties named
6
As Counterparty
mentioned by others
3
Rel. Types
2021-10-18
Earliest Filing
2025-05-30
Latest Filing
partner: 4
investor: 1
target: 1
Counterparties (Filed by LUCD)
6 relationshipsCompanies named in LUCD's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Maxim Group LLC | MMS | partner | Sales agent for the issuance and sale of Placement Shares | 2025-05-30 | View |
| CF Principal Investments LLC | — | investor | Investor purchasing common stock from the Company | 2022-04-01 | View |
| Lucid Diagnostics Inc. | LUCD | target | Company issuing and selling common stock to the Investor | 2022-04-01 | View |
| Cantor Fitzgerald & Co. | — | partner | Affiliate acting as Investor's representative | 2022-04-01 | View |
| ResearchDx, Inc. | — | partner | Consultant providing management services | 2022-03-03 | View |
| LucidDx Labs Inc. | LCID | partner | Company receiving management services | 2022-03-03 | View |
Mentioned As Counterparty
6 mentionsOther companies that named LUCD in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| PAVM PAVmed Inc. | partner | Company holds shares of Lucid Diagnostics Inc. and notes are exchangeable for its common stock. | 2024-11-21 | View |
| PAVM PAVmed Inc. | partner | Subsidiary being deconsolidated from PAVmed's financial statements | 2024-09-16 | View |
| PAVM PAVmed Inc. | partner | Majority owned subsidiary whose common stock was distributed to PAVmed Inc. stockholders via a special pro rata dividend | 2024-02-16 | View |
| PAVM PAVmed Inc. | partner | Majority-owned subsidiary of PAVmed Inc. that entered into a Common Stock Purchase Agreement with Cantor Fitzgerald. | 2022-04-01 | View |
| PAVM PAVmed Inc. | partner | Majority owned subsidiary of PAVmed Inc. that entered into an asset purchase agreement and management services agreement | 2022-03-03 | View |
| PAVM PAVmed Inc. | acquirer | PAVmed Inc. purchased majority ownership in Lucid Diagnostics Inc. following its initial public offering. | 2021-10-18 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-22 | Regulation FD; Exhibits | View | |
| 2026-08-13 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-06-24 | Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-05-14 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-04-24 | Regulation FD; Other Events; Exhibits | View | |
| 2026-04-23 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-03-26 | Earnings Release; Regulation FD; Exhibits | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-09-25 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-09-11 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-09-10 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-08-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-06-18 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-05-30 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-05-14 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-04-25 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-04-11 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-04-10 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-03-25 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-03-05 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR